CNOT6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.315600E-01
Normal-vs-Stage2
8.245400E-01
Normal-vs-Stage3
1.126000E-01
Normal-vs-Stage4
7.955200E-01
Stage1-vs-Stage2
5.105800E-01
Stage1-vs-Stage3
1.054970E-01
Stage1-vs-Stage4
8.941400E-01
Stage2-vs-Stage3
8.605900E-02
Stage2-vs-Stage4
4.511400E-01
Stage3-vs-Stage4
1.990820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.713200E-01
Normal-vs-AfricanAmerican
9.798400E-01
Normal-vs-Asian
7.104200E-01
Caucasian-vs-AfricanAmerican
7.181800E-01
Caucasian-vs-Asian
7.364800E-01
AfricanAmerican-vs-Asian
6.706800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.883400E-01
Normal-vs-Female
8.016000E-01
Male-vs-Female
8.946400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.887000E-01
Normal-vs-Age(41-60Yrs)
6.003400E-01
Normal-vs-Age(61-80Yrs)
5.121200E-01
Normal-vs-Age(81-100Yrs)
4.704600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.240400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.728200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.845000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.19769999999708E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.172100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.953000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.131200E-01
Normal-vs-Daily Drinker
6.251000E-01
Normal-vs-Weekly Drinker
6.374200E-01
Normal-vs-Occasional Drinker
9.429600E-01
Normal-vs-Social Drinker
9.410200E-01
Non Drinker-vs-Daily Drinker
8.711600E-01
Non Drinker-vs-Weekly Drinker
9.851200E-01
Non Drinker-vs-Occasional Drinker
2.672600E-01
Non Drinker-vs-Social Drinker
3.554800E-01
Daily Drinker-vs-Weekly Drinker
9.115400E-01
Daily Drinker-vs-Occasional Drinker
2.825200E-01
Daily Drinker-vs-Social Drinker
3.116000E-01
Weekly Drinker-vs-Occasional Drinker
3.632000E-01
Weekly Drinker-vs-Social Drinker
4.113600E-01
Occasional Drinker-vs-Social Drinker
8.103600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.041800E-01
Normal-vs-Grade 2
3.701800E-02
Normal-vs-Grade 3
1.954180E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.882300E-02
Grade 1-vs-Grade 3
1.605650E-02
Grade 1-vs-Grade 4
2.041800E-01
Grade 2-vs-Grade 3
4.659000E-01
Grade 2-vs-Grade 4
3.701800E-02
Grade 3-vs-Grade 4
1.954180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.902800E-01
Normal-vs-NonDiabetic
7.843000E-01
Diabetic-vs-NonDiabetic
1.739170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.018200E-01
Normal-vs-NoPancreatitis
7.296800E-01
Pancreatitis-vs-NoPancreatitis
7.590000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.781200E-01
Normal-vs-N1
8.147800E-01
N0-vs-N1
8.205000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.780200E-01
Normal-vs-TP53-NonMutant
9.844000E-01
TP53-Mutant-vs-TP53-NonMutant
6.265800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
